Edition:
United Kingdom

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

2.87USD
21 Sep 2018
Change (% chg)

$-0.33 (-10.31%)
Prev Close
$3.20
Open
$3.20
Day's High
$3.29
Day's Low
$2.87
Volume
18,504
Avg. Vol
24,259
52-wk High
$15.34
52-wk Low
$1.98

Chart for

About

Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and... (more)

Overall

Beta: --
Market Cap(Mil.): $214.98
Shares Outstanding(Mil.): 14.71
Dividend: --
Yield (%): --

Financials

  ALRN.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.24 -- --
ROI: -- 1.79 14.61
ROE: -- 3.28 16.33

BRIEF-Aileron Therapeutics Q1 Loss Per Share $0.52

* AILERON THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Aileron Therapeutics Reports Q4 Loss Of $0.47 Per Share

* AILERON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

02 Apr 2018

Earnings vs. Estimates